Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers
Cancers · 21.06.2023 · 15 (13) · 3277
DOI: 10.3390/cancers15133277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.06.2023. Verfasst von Sebastian O Oloo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Boron neutron capture therapy (BNCT) is a binary cancer treatment that involves the irradiation of 10B-containing tumors with low-energy neutrons (thermal or epithermal). The alpha particles and recoiling Li nuclei that are produced in the 10B-capture nuclear reaction are high-linear-energy transfer particles that destroy boron-loaded tumor cells; therefore, BNCT has the potential to be a localized therapeutic modality. Two boron-delivery agents have been used in clinical trials of BNCT in patients with malignant brain tumors, cutaneous melanoma, or recurrent tumors of the head and neck region, demonstrating the potential of BNCT in the treatment of difficult cancers. A variety of potentially highly effective boron-delivery agents have been synthesized in the past four decades and tested in cells and animal models. These include boron-containing nucleosides, peptides, proteins, polyamines, porphyrins, liposomes, monoclonal antibodies, and nanoparticles of various types. The most promising agents are multi-functional boronated molecules and nanoparticles functionalized with tumor cell-targeting moieties that increase their tumor selectivity and contain a radiolabel or fluorophore to allow quantification of 10B-biodistribution and treatment planning. This review discusses multi-functional boron agents reported in the last decade, but their full potential can only be ascertained after their evaluation in BNCT clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA.
ORCID-Profile: Sebastian O Oloo, Kevin M Smith, Maria da Graça H Vicente
Förderung
- National Science Foundation
Zitieren
APA
Oloo, S. O., Smith, K. M., & Vicente, M. D. G. H. (2023). Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers. Cancers, 15(13), 3277. https://doi.org/10.3390/cancers15133277
Vancouver
Oloo SO, Smith KM, Vicente MDGH. Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers. Cancers. 2023;15(13):3277. doi:10.3390/cancers15133277
BibTeX
@article{Oloo2023,
author = {Oloo, Sebastian O and Smith, Kevin M and Vicente, Maria da Graça H},
title = {Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers},
journal = {Cancers},
year = {2023},
volume = {15},
number = {13},
pages = {3277},
doi = {10.3390/cancers15133277}
}
EUVIMED